Medicare Weighs Premium Cut after Limiting Alzheimer's Drug

WASHINGTON — Medicare said Thursday it's considering a cut in enrollee premiums, after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer's drug projected to drive up program costs.

The agency “is looking at that, and is still going through the process,”

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Washington ,United States ,Xavier Becerra ,Harry Johns ,Beth Lynk ,Joe Biden ,Lee Fleisher ,Tamara Syrek Jensen ,Centers For Medicare Medicaid Services ,Human Services ,National Institutes Of Health ,Alzheimer Association ,Drug Administration ,National Institutes ,Human Services Secretary Xavier Becerra ,President Joe Biden ,Social Security ,Medicaid Services ,Syrek Jensen ,